Singapore markets closed
Straits Times Index
3,290.70 +24.75 (+0.76%) Nikkei
38,229.11 +155.13 (+0.41%) Hang Seng
18,963.68 +425.87 (+2.30%) FTSE 100
8,433.76 +52.41 (+0.63%) Bitcoin USD
60,891.87 -1,702.80 (-2.72%) CMC Crypto 200
1,258.17 -99.84 (-7.35%)
Amedisys, Inc. (ADY.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 09:38AM CEST
| Previous close | 86.00 |
| Open | 86.00 |
| Bid | 87.50 x 10000 |
| Ask | 90.00 x 10000 |
| Day's range | 86.00 - 89.00 |
| 52-week range | 67.00 - 89.00 |
| Volume | |
| Avg. volume | 5 |
| Market cap | 2.975B |
| Beta (5Y monthly) | 0.84 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.59 |
| Earnings date | 24 Jul 2024 - 29 Jul 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 230.13 |
ZacksAmedisys (AMED) Q1 Earnings Surpass Estimates, Margins Rise
Amedisys (AMED) tops on revenue and earnings estimates in the first quarter of fiscal 2024.
ZacksCompared to Estimates, Amedisys (AMED) Q1 Earnings: A Look at Key Metrics
The headline numbers for Amedisys (AMED) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
ZacksAmedisys (AMED) Q1 Earnings and Revenues Surpass Estimates
Amedisys (AMED) delivered earnings and revenue surprises of 1.98% and 1.21%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.